Rehabilitating drug-induced long-QT promoters: in-silico design of hERG-neutral cisapride analogues with retained pharmacological activity. - Durdagi S; Randall T; Duff HJ; Chamberlin A; Noskov SY (BMC pharmacology & toxicology, 2014)